Benefits and Risks of Preventing Thromboembolism With Enoxaparin in Patients With General Surgery in Real World—The CLEVER Study

  • Sebastian M. Schellong, Albrecht Encke, Artur-Aaron Weber, Peter Bramlage, W. Dieter Paar, Sylvia Haas
  • Clinical and Applied Thrombosis/Hemostasis, October 2012, SAGE Publications
  • DOI: 10.1177/1076029612461067

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Peter Bramlage